LEXX Latest Press Releases

-- October 28, 2026 --

Lexaria Celebrates its 70th Patent Award ACCESS Newswire 9:10 AM

-- October 21, 2026 --

-- October 15, 2026 --

Lexaria Announces Results from Animal Study GLP-1-A26-1 ACCESS Newswire 9:10 AM

-- October 6, 2026 --

GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications ACCESS Newswire 9:10 AM

-- September 17, 2026 --

Lexaria Updates Financial Position ACCESS Newswire 9:10 AM

-- September 9, 2026 --

-- September 8, 2026 --

-- September 4, 2026 --

Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference ACCESS Newswire 9:20 AM

-- September 1, 2026 --

Lexaria Receives USD$2.6 Million Tax Rebate Payment ACCESS Newswire 9:15 AM

-- August 24, 2026 --

-- August 13, 2026 --

Lexaria Enters a Material Transfer Agreement With PegBio ACCESS Newswire 9:00 AM

-- July 30, 2026 --

Lexaria Announces Effective Date for Reverse Stock Split ACCESS Newswire 11:00 AM

-- July 6, 2026 --

Lexaria Updates Business Development ACCESS Newswire 9:10 AM

-- June 25, 2026 --

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule ACCESS Newswire 9:10 AM

-- June 23, 2026 --

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule ACCESS Newswire 9:25 AM

-- June 17, 2026 --

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand ACCESS Newswire 9:25 AM

-- June 9, 2026 --

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway ACCESS Newswire 9:25 AM

-- June 3, 2026 --